🇺🇸 FDA
Patent

US 7446182

Recombinant antibodies for the detection and neutralization of anthrax toxin

granted A61KA61K2039/505A61P

Quick answer

US patent 7446182 (Recombinant antibodies for the detection and neutralization of anthrax toxin) held by The Board of Regents of the University of Texas System expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/505, A61P, A61P31/04